Published in Hospital Business Week, June 27th, 2004
According to recent research published in the journal Cancer Treatment Reviews, "As we enter the third decade of the AIDS epidemic, it is apparent that a large number of cancers are more common in people with the human immunodeficiency virus type 1 (HIV-1). Non-Hodgkin's lymphoma (NHL) remains the second most common tumor in such patients. At the onset of the epidemic, dose-intense combination regimens were used but these were quickly abandoned in favor of dose-modified strategies because of difficulties in tolerating aggressive chemotherapy in the presence of underlying...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.